Page last updated: 2024-08-24

cephalosporin c and technetium tc 99m dimercaptosuccinic acid

cephalosporin c has been researched along with technetium tc 99m dimercaptosuccinic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, C; Bischoff, G; Buechner, K; Gervaix, A; Girardin, E; Goetschel, P; Hunziker, U; Husarik, D; Molinari, L; Nadal, D; Neuhaus, TJ; Parvex, P; Rudin, C; Stocker, S; Willi, U1
Kim, JJ; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoo, KH1

Trials

2 trial(s) available for cephalosporin c and technetium tc 99m dimercaptosuccinic acid

ArticleYear
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis.
    European journal of pediatrics, 2008, Volume: 167, Issue:9

    Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ceftibuten; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Pyelonephritis; Radionuclide Imaging; Technetium Tc 99m Dimercaptosuccinic Acid

2008
The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI.
    European journal of pediatrics, 2012, Volume: 171, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cicatrix; Female; Fever; Humans; Infant; Kidney; Male; Pyelonephritis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Dimercaptosuccinic Acid; Time Factors; Treatment Outcome; Urinary Tract Infections; Vesico-Ureteral Reflux

2012